Holobiome Wins USD1 Million in Research Funding from CSB to Advance Microbiome Solutions for Pain
The project sponsorship follows Corundum Systems Biology's June 2021 seed stage capital investment in Holobiome.
- The project sponsorship follows Corundum Systems Biology's June 2021 seed stage capital investment in Holobiome.
- Holobiome was established in 2018 to advance human microbiome science beyond academia, with a particular focus on the relationship between the human gut and the brain.
- Recent research by Holobiome and by its scientific advisors has implicated microbial influences on modulating neurotransmission along the gut-brain-axis.1,2,3
"Recent evidence suggests the microbiome plays a role in regulating pain sensitivity and the inflammatory response," says Holobiome's CEO Dr. Philip Strandwitz. - "The future of microbiome therapeutics will be precision, and this project will drive that future," Dr. Strandwitz says.